Parasite enzyme shows promise for Crohn's in early trial
NCT ID NCT02281916
First seen Dec 26, 2025 · Last updated May 15, 2026 · Updated 23 times
Summary
This study tested a new drug called P28GST, made from a parasite enzyme, to see if it is safe for people with moderate Crohn's disease. Ten adults with Crohn's took part, some before or after bowel surgery. The goal was to check for side effects and see if the drug could help control inflammation.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CROHN'S ILEOCOLITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHRU, Hôpital Claude Huriez
Lille, 59037, France
-
Centre Hospitalier Dunkerque
Dunkirk, France
-
Centre Hospitalier de Boulogne
Boulogne-sur-Mer, France
-
Centre Hospitalier,
Valenciennes, France
-
Centre hospitalier
Amiens, France
Conditions
Explore the condition pages connected to this study.